| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Human |
| Target | RhD |
| Clinical data | |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
 
(what is this?)
(verify) | |
Morolimumab is a human monoclonal antibody against the human Rhesus factor. [1] [2]
References
- ^ "Proposed International Nonproprietary Names: Morolimumab" (PDF). WHO Drug Information. 13 (1). Geneva: World Health Organization: 45. 1991.
- ^ Pelletier JP, Mukhtar F (2020). "Chapter 16 - Passive Monoclonal and Polyclonal Antibody Therapies". In Maitta RW (ed.). Immunologic Concepts in Transfusion Medicine. Philadelphia: Elsevier. p. 300. doi: 10.1016/B978-0-323-67509-3.00016-0. ISBN 978-0-323-67510-9. S2CID 213508934.
 | This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |
 | This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |